Status:
COMPLETED
A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
COPD
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This multi-center study is designed to describe natural history of disease, treatment and health care products in physician-diagnosed COPD patients who require adding daily maintenance therapy in real...
Eligibility Criteria
Inclusion
- Willing and able to provide informed consent
- Physician-diagnosis of COPD
- COPD patients requiring long-acting bronchodilator treatment
- Patients with spirometry available at baseline
Exclusion
- Patients who have a diagnosis of asthma.
- Patients who had been hospitalized for a COPD exacerbation in the 4 weeks prior to Visit 1.
- Current clinical diagnosis of other chronic respiratory illnesses
- Concurrent participation in a clinical trial or use of an investigational drug.
- Active malignancy or history of malignancy of any organ system
- Pregnant or nursing (lactating) women
- Women of child-bearing potential with no contraception Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
February 5 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2015
Estimated Enrollment :
2229 Patients enrolled
Trial Details
Trial ID
NCT01794780
Start Date
February 5 2013
End Date
May 25 2015
Last Update
September 26 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis Investigative Site
Beijing, China, 100730
2
Novartis Investigative Site
Zhengzhou, China